{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:46:33Z","timestamp":1762854393670,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:00:00Z","timestamp":1700697600000},"content-version":"am","delay-in-days":357,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.gofs.2022.11.001","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T07:41:56Z","timestamp":1669275716000},"page":"807-809","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Faut-il craindre les fluoroquinolones chez une femme enceinte ou qui allaite\u00a0?"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6174-3615","authenticated-orcid":false,"given":"C.","family":"Vauzelle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.gofs.2022.11.001_bib0005","unstructured":"Haute Autorit\u00e9 de sant\u00e9 (HAS). Commission de la transparence Avis 21\u00a0mars 2018, https:\/\/www.has-sante.fr\/upload\/docs\/evamed\/CT-16655_NORFLOXACINE_PIS_REEV_Avis3.pdf (accessed 9\u00a0octobre 2022)."},{"key":"10.1016\/j.gofs.2022.11.001_bib0010","unstructured":"S. Lejeune. Les fluoroquinolones. Dipl\u00f4me Universitaire de Th\u00e9rapeutiques Anti-Infectieuses Universit\u00e9 Grenoble Alpes 1\u00e8re session\u2013Janvier 2022 (28-01-2021) https:\/\/www.infectiologie.com\/UserFiles\/File\/formation\/du\/grenoble\/dutai-grenoble-2021-22-fluroquinolones-slejeune.pdf (accessed 9\u00a0octobre 2022)."},{"key":"10.1016\/j.gofs.2022.11.001_bib0015","unstructured":"Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM). Antibiotiques de la famille des quinolones et fluoroquinolones administr\u00e9s par voie syst\u00e9mique ou inhal\u00e9e\u00a0: risque d\u2019effets ind\u00e9sirables invalidants, durables et potentiellement irr\u00e9versibles et restrictions d\u2019utilisation. Publi\u00e9 le 10\/04\/2019 - mis \u00e0 jour le 15\/04\/2021. (accessed 17\u00a0octobre 2022) https:\/\/ansm.sante.fr\/informations-de-securite\/antibiotiques-de-la-famille-des-quinolones-et-fluoroquinolones-administres-par-voie-systemique-ou-inhalee-risque-deffets-indesirables-invalidants-durables-et-potentiellement-irreversibles-et-restrictions-dutilisation."},{"key":"10.1016\/j.gofs.2022.11.001_bib0020","unstructured":"Agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9 (ANSM). Dossier th\u00e9matique Fluoroquinolones. Publi\u00e9 le 20\/10\/2022 https:\/\/ansm.sante.fr\/dossiers-thematiques\/fluoroquinolones (accessed 20\u00a0octobre 2022)."},{"issue":"5","key":"10.1016\/j.gofs.2022.11.001_bib0025","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1179\/1973947815Y.0000000054","article-title":"Fluoroquinolones in children: update of the literature","volume":"27","author":"Bacci","year":"2015","journal-title":"J Chemother"},{"issue":"9","key":"10.1016\/j.gofs.2022.11.001_bib0030","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/1471-0528.15119","article-title":"The safety of quinolones and fluoroquinolones in pregnancy: a meta-analysis","volume":"125","author":"Yefet","year":"2018","journal-title":"BJOG"},{"issue":"9","key":"10.1016\/j.gofs.2022.11.001_bib0035","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1111\/1471-0528.17083","article-title":"Ciprofloxacin exposure and adverse pregnancy outcomes: a Danish nationwide cohort study","volume":"129","author":"Noergaard","year":"2022","journal-title":"BJOG"},{"issue":"10","key":"10.1016\/j.gofs.2022.11.001_bib0040","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1086\/598191","article-title":"Drug-resistant tuberculosis and pregnancy: treatment outcomes of 38\u00a0cases in Lima, Peru","volume":"48","author":"Palacios","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.gofs.2022.11.001_bib0045","first-page":"1536281","article-title":"Multidrug-resistant tuberculosis during pregnancy: two case reports and review of the literature","volume":"2016","author":"Rohilla","year":"2016","journal-title":"Case Rep Obstet Gynecol"},{"key":"10.1016\/j.gofs.2022.11.001_bib0050","unstructured":"R\u00e9sum\u00e9 des caract\u00e9ristiques du produit CILOXAN 0,3\u00a0pour cent, collyre. Base de donn\u00e9es publique des m\u00e9dicaments. https:\/\/base-donnees-publique.medicaments.gouv.fr\/affichageDoc.php?specid=69501024&typedoc=R (accessed 17\u00a0octobre 2022)."},{"key":"10.1016\/j.gofs.2022.11.001_bib0055","unstructured":"R\u00e9sum\u00e9 des caract\u00e9ristiques du produit CILOXAN 3mg\/ml, solution pour instillation auriculaire. https:\/\/base-donnees-publique.medicaments.gouv.fr\/affichageDoc.php?specid=67901977&typedoc=R (accessed 17\u00a0octobre 2022)."},{"key":"10.1016\/j.gofs.2022.11.001_bib0060","unstructured":"CRAT, Ciprofloxacine - Grossesse et allaitement. http:\/\/www.lecrat.fr\/articlePrint.php?id_article=379 (accessed 17\u00a0octobre 2022)."},{"key":"10.1016\/j.gofs.2022.11.001_bib0065","unstructured":"CRAT, Ofloxacine - Grossesse et allaitement. http:\/\/www.lecrat.fr\/articlePrint.php?id_article=384 (accessed 17\u00a0octobre 2022)."},{"key":"10.1016\/j.gofs.2022.11.001_bib0070","unstructured":"CRAT, Fluoroquinolones - Grossesse et allaitement. http:\/\/www.lecrat.fr\/articlePrint.php?id_article=491 (accessed 17\u00a0octobre 2022)."}],"container-title":["Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718922003208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468718922003208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T09:42:05Z","timestamp":1762854125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468718922003208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":14,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S2468718922003208"],"URL":"https:\/\/doi.org\/10.1016\/j.gofs.2022.11.001","relation":{},"ISSN":["2468-7189"],"issn-type":[{"type":"print","value":"2468-7189"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Faut-il craindre les fluoroquinolones chez une femme enceinte ou qui allaite\u00a0?","name":"articletitle","label":"Article Title"},{"value":"Gyn\u00e9cologie Obst\u00e9trique Fertilit\u00e9 & S\u00e9nologie\u00a0","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gofs.2022.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}